Skip to main content

Table 3 Distribution of antiviral regimens among 334 HIV/HBV co-infected patients on current anti-HBV treatment

From: Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy

Treatment

n

(%)

TDF + LAM/FTC

235

70.4

LAM

60

18

TDF

17

5.1

Telbivudine

6

1.8

PEG-IFN §

6

1.8

Other combo NUC *

5

1.5

ETV

3

0.9

ADV

2

0.6

Total

334

100

  1. § + TDF = 4; *ADV + LAM =4, ADV + ETV =1.
Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us